Liabilities, Current of BriaCell Therapeutics Corp. from 31 Jul 2021 to 31 Oct 2025

Taxonomy & unit: us-gaap: USD
Description: Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
Summary: BriaCell Therapeutics Corp. quarterly Liabilities, Current in USD history and change rate from 31 Jul 2021 to 31 Oct 2025.
BriaCell Therapeutics Corp. Liabilities, Current for the quarter ending 31 Oct 2025 was $3,317,773, a 33% decline year-over-year.
Source SEC data: View on sec.gov

Liabilities, Current, Quarterly (USD)

Liabilities, Current, YoY Quarterly Change (%)

BriaCell Therapeutics Corp. Quarterly Liabilities, Current (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q3 2025	$3,317,773	-$1,670,863	-33%	31 Oct 2025	10-Q	11 Dec 2025	2026	Q1
Q2 2025	$3,977,988	-$3,483,169	-47%	31 Jul 2025	10-Q	11 Dec 2025	2026	Q1
Q1 2025	$4,330,633	-$2,427,126	-36%	30 Apr 2025	10-Q	16 Jun 2025	2025	Q3
Q4 2024	$5,230,838	+$1,306,513	+33%	31 Jan 2025	10-Q	12 Mar 2025	2025	Q2
Q3 2024	$4,988,636	+$3,942,131	+377%	31 Oct 2024	10-Q	16 Dec 2024	2025	Q1
Q2 2024	$7,461,157	+$5,659,700	+314%	31 Jul 2024	10-K	16 Oct 2025	2025	FY
Q1 2024	$6,757,759	+$5,374,665	+389%	30 Apr 2024	10-Q	14 Jun 2024	2024	Q3
Q4 2023	$3,924,325	+$3,253,912	+485%	31 Jan 2024	10-Q	18 Mar 2024	2024	Q2
Q3 2023	$1,046,505	+$72,455	+7.4%	31 Oct 2023	10-Q	14 Dec 2023	2024	Q1
Q2 2023	$1,801,457	+$860,370	+91%	31 Jul 2023	10-K	29 Oct 2024	2024	FY
Q1 2023	$1,383,094			30 Apr 2023	10-Q	14 Jun 2023	2023	Q3
Q4 2022	$670,413			31 Jan 2023	10-Q	16 Mar 2023	2023	Q2
Q3 2022	$974,050			31 Oct 2022	10-Q	14 Dec 2022	2023	Q1
Q2 2022	$941,087	+$384,292	+69%	31 Jul 2022	10-K	25 Oct 2023	2023	FY
Q2 2021	$556,795			31 Jul 2021	10-K	28 Oct 2022	2022	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.